Table 1.
Therapy Type | Drug Name | Under | FDA Status |
---|---|---|---|
Small Molecule | Metformin | Alzheimer’s Disease | AD (Phase 2/3) |
Supplement, Dietary, Small Molecule | Resveratrol | Alzheimer’s Disease Mild Cognitive Impairment |
AD (Phase 3) MCI (Phase 4) |
Supplement, Dietary | Epigallocatechin Gallate (EGCG) | Alzheimer’s Disease | AD (Phase 2/3) |
Small Molecule | Dexpramipexole | Alzheimer’s Disease Amyotrophic Lateral Sclerosis |
AD (Phase 2) ALS (Discontinued) |
Small Molecule | Masitinib | Alzheimer’s Disease Amyotrophic Lateral Sclerosis |
AD (Phase 3) ALS (Phase 3) |
Passive Immunotherapy | TB006 | Alzheimer’s Disease | AD (Phase 1) |